Trust Point Inc’s Edwards Lifesciences EW Stock Holding History

Trust Point Inc’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$776K	Buy	+8,991	New	+$799K	0.06%	172
2026 Q2	–	Sell	-8,551	Closed	-$685K	–	523
2026 Q1	$685K	Sell	8,551 -190	-2%	-$15.7K	0.06%	175
2025 Q4	$745K	Sell	8,741 -95	-1%	-$7.8K	0.06%	162
2025 Q3	$687K	Buy	+8,836	New	+$690K	0.06%	164
2025 Q2	–	Sell	-8,780	Closed	-$636K	–	437
2025 Q1	$636K	Sell	8,780 -582	-6%	-$41.7K	0.06%	178
2024 Q4	$693K	Sell	9,362 -1,622	-15%	-$114K	0.05%	222
2024 Q3	$725K	Sell	10,984 -548	-5%	-$39.8K	0.05%	213
2024 Q2	$1.07M	Sell	11,532 -419	-4%	-$37.1K	0.09%	139
2024 Q1	$1.14M	Buy	11,951 +599	+5%	+$50.3K	0.09%	131
2023 Q4	$866K	Buy	+11,352	New	+$790K	0.07%	159

Other funds holding EW

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Mirova US Boston, Massachusetts $9.15B AUM 21.91% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return

Trust Point Inc's EW Position: Q3 2026 in Review

Trust Point Inc opened a new position in Edwards Lifesciences (EW) in Q3 2026: 8,991 shares worth $776K. The stake represents 0.06% of the portfolio and ranks #172 among its holdings. This is a return to the name: Trust Point Inc previously reported a position in EW as recently as Q1 2026.

Trust Point Inc first reported a position in EW in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.14M in Q1 2024. 719 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Trust Point Inc held 8,991 shares of Edwards Lifesciences worth $776K as of Q3 2026.
Edwards Lifesciences was a new Trust Point Inc position in Q3 2026.
Edwards Lifesciences made up 0.06% of Trust Point Inc's portfolio in Q3 2026, its #172 holding.
Trust Point Inc first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 10 quarters since.
Trust Point Inc's Edwards Lifesciences position peaked at $1.14M in Q1 2024.
719 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Trust Point Inc's 13F filing for Q3 2026, filed 27 Oct 2026.